MLSS - Milestone Scientific Corporation Long-Term Liabilities to Capital

This chart on GURU.Markets illustrates the long-term debt-to-equity ratio for Milestone Scientific (MLSS) via 0.14, reflecting the metric's most recent value. Milestone Scientific utilizes proprietary injection control to create customer dependency on disposable needles. The model aims for dominance in the painless anesthetic delivery segment. The company is currently scaling sales of CompuFlo systems within obstetrics and dentistry, expanding its B2B distribution.

For Milestone Scientific (MLSS), which focuses on patents and marketing via outsourced production, borrowing control is critical for vendor management. The ratio measures the share of liabilities with a maturity exceeding one year relative to equity. By analyzing the ratio of long-term loans to equity, an investor assesses the risk of insolvency during market downturns. An optimal balance prevents growth stagnation and excessive debt load. Such a strategy ensures the sustainability of a business model that avoids capital expenditures on factories.